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MMC has been awarded 
$2.6 million by the Patient-
Centered Outcomes Re-
search Institute (PCORI) to 
study whether early trache-
ostomy in severely ill stroke 
patients who require me-
chanical ventilation im-
proves survival, recovery 
and the patient and family 
experience.  
 
A tracheostomy is a tempo-
rary surgical airway that 
provides a more comforta-
ble alternative for delivering 
oxygen to the lungs when a 
stroke patient’s breathing 
has failed. 
 
The research study will be 
led by David Seder, M.D., 
Director of MMC’s Neuro-
critical Care team and a 
principal investigator at the 
Maine Medical Center Re-
search Institute. 
 
Prior studies have suggested 
that when patients whose 
breathing has failed after a 
severe stroke undergo tra-
cheostomy early in the 
course of their recovery, the  
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David Seder, M.D., Director of MMC’s Neurocritical Care team 
and a principal investigator at the Maine Medical Center Research 
Institute, will lead the study. 
Flu Masking Is In Effect 
 
Flu is on the rise in Maine, and our Epidemiology and Infec-
tion Prevention team has confirmed cases of influenza at the 
hospital. MMC is taking extra precautions to protect the 
health of patients and employees. All employees should fol-
low these guidelines: 
 
 Masking is in effect. If you are not vaccinated against 
influenza, you must wear a surgical mask whenever 
you are within six feet of a patient. This includes times 
of direct contact. 
 Always follow proper hand hygiene and cough etiquette. 
 If you are experiencing cold-like symptoms, regardless of 
your influenza immunization status, you must mask. 
 If you have a fever, stay home. 
  
Always follow these guidelines, and speak with your manager if you have any concerns. 
Employees can still get a flu vac-
cine. Call Employee Health, 662-
4011, to make an appointment. 
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risks of pneumonia and  
other complications that 
can lead to a prolonged 
hospital stay and death are 
lower. 
 
However, the common 
practice in many hospitals is 
to delay the tracheostomy 
procedure for up to three 
weeks, in case the patient 
recovers airway protective 
reflexes. 
 
“This research study tests 
whether a reversible trache-
ostomy in patients with res-
piratory failure after stroke, 
performed earlier than is 
currently standard practice, 
results in shorter duration 
of coma, earlier rehab activ-
ities, shorter duration of 
mechanical ventilation, im-
proved survival and im-
proved long-term function-
al outcomes,” said Dr. Se-
der. “If successful, the trial 
could change the way such 
patients are treated world-
wide, and has the potential 
to dramatically improve the 
outcomes of the sickest 
stroke patients.” 
 
He continued, “The study 
will also assess other poten-
tial benefits of the early in-
tervention such as a short-
ened duration of coma, im-
proved patient comfort and 
a better ability to communi-
cate with the patient.” 
 
The study, called SET-
POINT2: A Pragmatic Trial 
to Test the Effectiveness of Early 
vs. Delayed Percutaneous Tra-
cheostomy in Patients with Se-
vere Stroke and Respiratory 
Failure, is a collaboration 
between MMC, the Univer-
sity of Heidelberg and the 




Dr. Seder is partnering with 
the Maine Medical Center 
Research Institute 
(MMCRI) and MMC’s Neu-
roscience Institute on the 
study. PCORI also consid-
ers patients, families, and 
other key stakeholders to be 
key collaborators in the re-
search process. The US 
SETPOINT2 research advi-
sory committee will include 
MMC Chaplain Alice Hilde-
brandt, MMC stroke survi-
vor family member Danielle 
Phinney, a representative of 
the American Heart Associ-
ation/American Stroke As-
sociation and several others.  
 
“Maine Medical Center and 
its Research Institute are 
proud to be named as the 
U.S. coordinating center for 
the $2.6 million SET-
POINT 2 clinical trial. This 
multi-site, international re-
search project is designed to 
test the most effective 
method of providing respir-
atory support to critically ill 
stroke patients in an inten-
sive care unit setting,” said 
Donald St. Germain, M.D., 
Vice President, Research, 
MMC and Director, 
MMCRI. “The results of 
this project will define a 
critically important set of 
standards to guide the care 
of severely ill stroke pa-
tients. It represents the ded-
icated efforts of highly 
skilled critical care teams 
around the world and the 
commitment and support 
of MMC, its collaborating 
institutions and PCORI to 
provide the best care possi-
ble for patients suffering 
from stroke.” 
 
Dr. Seder’s award has been 
approved pending comple-
tion of a business and pro-
grammatic review by 
PCORI staff and issuance 
of a formal award contract. 
 
“This project was selected 
for PCORI funding not on-
ly for its scientific merit and 
commitment to engaging 
patients and other stake-
holders, but also for its po-
tential to fill an important 
gap in our health 
knowledge and give people 
information to help them 
weigh the effectiveness of 
their care options,” said 
PCORI Executive Director 
Joe Selby, M.D., MPH. “We 
look forward to following 
the study’s progress and 
working with Maine Medi-
cal Center to share the re-
sults.”  
Nursing Excellence Awards Nominations 
Deadline:  March 1 
 
Nominations for the 2017 Nursing Excellence Awards 
are now being accepted. 
Guidelines and criteria are on the Nursing page of the MMC Intranet. 
